{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:02:10Z","timestamp":1793916130550,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024075","name":"Region of Southern Denmark","doi-asserted-by":"publisher","award":["19\/12166"],"award-info":[{"award-number":["19\/12166"]}],"id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["4004-001"],"award-info":[{"award-number":["4004-001"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NN23OC0086062"],"award-info":[{"award-number":["NN23OC0086062"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF16OC0021038"],"award-info":[{"award-number":["NNF16OC0021038"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danish National Research Foundation","doi-asserted-by":"publisher","award":["DNRF141"],"award-info":[{"award-number":["DNRF141"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhepr.2025.101432","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T19:22:04Z","timestamp":1745349724000},"page":"101432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ability of soluble TREM2 and PRO-C3 as biomarkers to predict changes in MASLD activity"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8964-0650","authenticated-orcid":false,"given":"Charlotte Wilhelmina","family":"Wernberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2160-9379","authenticated-orcid":false,"given":"Vineesh","family":"Indira Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Munk","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1366-2911","authenticated-orcid":false,"given":"Maria Kl\u00f8jgaard","family":"Skytthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-2485","authenticated-orcid":false,"given":"Camilla Dalby","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2898-5369","authenticated-orcid":false,"given":"Johanne Kragh","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5754-8235","authenticated-orcid":false,"given":"Lea Ladegaard","family":"Gr\u00f8nkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte Gade","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Di Caterino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-2333","authenticated-orcid":false,"given":"S\u00f6nke","family":"Detlefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1854-1924","authenticated-orcid":false,"given":"Maja","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Mayorca","family":"Guiliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7921-9707","authenticated-orcid":false,"given":"Ida Falk","family":"Villesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4256-140X","authenticated-orcid":false,"given":"Diana Julie","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7119-2108","authenticated-orcid":false,"given":"Jonas Heilskov","family":"Graversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9598-4932","authenticated-orcid":false,"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101432_bib1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jhep.2022.11.028","article-title":"NAFLD and NASH biomarker qualification in the LITMUS consortium; lessons learned","volume":"78","author":"Rasmussen","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101432_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101432_bib3","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2025.101432_bib4","series-title":"Phase 3 ESSENCE trial: semaglutide in metabolic dysfunction-associated steatohepatitis (MASH). [Abstract] the Liver Meeting\u00ae; Nov 15\u201319, 2024","author":"Newsome","year":"2024"},{"key":"10.1016\/j.jhepr.2025.101432_bib5","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.cgh.2023.03.041","article-title":"Clinical trial landscape in NASH","volume":"21","author":"Harrison","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101432_bib6","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101432_bib7","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101432_bib8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2021.10.029","article-title":"Non-invasive evaluation of response to obeticholic acid in patients with NASH: results from the REGENERATE study","volume":"76","author":"Rinella","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101432_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep4.1657","article-title":"Effects of resmetirom on noninvasive endpoints in a 36-week phase 2 active treatment extension study in patients with NASH","volume":"5","author":"Harrison","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101432_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00535-010-0311-8","article-title":"Prevalence, gender, ethnic variations, and prognosis of NASH","volume":"46","author":"Hashimoto","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101432_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2022.06.004","article-title":"Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH","volume":"77","author":"Hendrikx","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101432_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.32620","article-title":"Circulating TREM2 as a non-invasive diagnostic biomarker for NASH in patients with elevated liver stiffness","volume":"77","author":"Chandran","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101432_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2025.101432_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","article-title":"A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures","volume":"5","author":"Govaere","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhepr.2025.101432_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhepr.2019.06.004","article-title":"Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease","volume":"1","author":"Boyle","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101432_bib16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.30163","article-title":"ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis","volume":"69","author":"Daniels","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101432_bib17","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jhep.2021.08.016","article-title":"Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population","volume":"75","author":"Nielsen","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101432_bib18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/apt.16567","article-title":"Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation","volume":"54","author":"Thiele","year":"2021","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.jhepr.2025.101432_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.510280115","article-title":"Collagen XVIII is localized in sinusoids and basement membrane zones and expressed by hepatocytes and activated stellate cells in fibrotic human liver","volume":"28","author":"Musso","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101432_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M22-1787","article-title":"Effect of calorie-unrestricted low-carbohydrate, high-fat diet versus high-carbohydrate, low-fat diet on type 2 diabetes and nonalcoholic fatty liver disease","volume":"176","author":"Camilla","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhepr.2025.101432_bib21","first-page":"303","article-title":"The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jhepr.2025.101432_bib22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1872-034X.2011.00946.x","article-title":"Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): a marker related to the extracellular matrix remodeling during liver fibrogenesis","volume":"42","author":"Leeming","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2025.101432_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024753","article-title":"MMP mediated degradation of type VI collagen is highly associated with liver fibrosis\u2013identification and validation of a novel biochemical marker assay","volume":"6","author":"Veidal","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2025.101432_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.clinbiochem.2016.05.023","article-title":"Type VIII collagen is elevated in diseases associated with angiogenesis and vascular remodeling","volume":"49","author":"Hansen","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jhepr.2025.101432_bib25","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.25993","article-title":"Determination of reliability criteria for liver stiffness evaluation by transient elastography","volume":"57","author":"Boursier","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101432_bib26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101432_bib27","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","article-title":"Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease","volume":"154","author":"Thiele","year":"2018","journal-title":"Gastroenterology"},{"issue":"S1","key":"10.1016\/j.jhepr.2025.101432_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/liv.13653","article-title":"Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: why liver biopsy is essential","volume":"38","author":"Bedossa","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101432_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1590\/S1678-9946201658010","article-title":"Liver biopsy: importance of specimen size in the diagnosis and staging of chronic viral hepatitis","volume":"58","author":"Coral","year":"2016","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jhepr.2025.101432_bib30","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jhepr.2025.101432_bib31","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00125-017-4340-1","article-title":"Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study","volume":"60","author":"Isokuortti","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2025.101432_bib32","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European association for the study of obesity. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101432_bib33","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-013-2948-3","article-title":"What do we learn from measurements of HOMA-IR?","volume":"56","author":"Reaven","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2025.101432_bib34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101432_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.matbio.2016.10.002","article-title":"Collagen XVIII in tissue homeostasis and dysregulation \u2014 lessons learned from model organisms and human patients","volume":"57\u201358","author":"Heljasvaara","year":"2017","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhepr.2025.101432_bib36","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1038\/s41598-017-05257-5","article-title":"Complementary role of fibroblast growth factor 21 and cytokeratin 18 in monitoring the different stages of nonalcoholic fatty liver disease","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101432_bib37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2023.04.031","article-title":"NIS2+\u2122, an optimisation of the blood-based biomarker NIS4\u00ae technology for the detection of at-risk NASH: a prospective derivation and validation study","volume":"79","author":"Harrison","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101432_bib38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00125-013-3145-0","article-title":"Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus","volume":"57","author":"Hogan","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2025.101432_bib39","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1210\/jc.2004-0436","article-title":"Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin","volume":"89","author":"Dandona","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2025.101432_bib40","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jdiacomp.2015.12.017","article-title":"Diabetes medications: impact on inflammation and wound healing","volume":"30","author":"Salazar","year":"2016","journal-title":"J Diabetes Complications"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925001090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925001090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T08:07:39Z","timestamp":1755245259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925001090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2589555925001090"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101432","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ability of soluble TREM2 and PRO-C3 as biomarkers to predict changes in MASLD activity","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101432"}}